News | May 12, 2023
Sanofi India to demerge healthcare businesses
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Bridging the gap between histopathology and molecular pathology
Subscribe To Our Newsletter & Stay Updated
